Tag: joint pain injections market share

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Joint Pain Injections Global Market Report 2024, the joint pain injections market is expected to show promising growth in the forecast period.

The joint pain injections market has witnessed a rapid and substantial growth trajectory in recent years, driven by factors such as an aging population, increased arthritis prevalence, and the global focus on healthcare digitalization. This blog delves into the current dynamics of the joint pain injections market, exploring growth projections, significant trends, and noteworthy developments within the industry.

Market Growth and Projections

Current Growth and Future Projections

The joint pain injections market, valued at $5.19 billion in 2023, is set to grow to $5.75 billion in 2024, boasting a commendable compound annual growth rate (CAGR) of 10.9%. Looking forward, the market is poised for rapid expansion, with a projected value of $8.8 billion by 2028 and an expected CAGR of 11.2%. This growth is attributed to various factors, including the expansion of telehealth services, personalized pain management, and sustainable healthcare practices.

Elevated Prevalence Of Arthritis And Musculoskeletal Disorders Drives Growth

Scope and Impact of Musculoskeletal Disorders

The increasing prevalence of arthritis and musculoskeletal disorders emerges as a significant driver for the joint pain injections market. These disorders, major causes of disability globally, impact around 1.71 billion people worldwide. In 2021, arthritis affected approximately 350 million people, with low back pain being a common cause of impairment in 160 nations. The rising numbers underscore the critical need for effective joint pain solutions.

Key Players in the Market

Major companies contributing to the growth of the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., and several others. These companies play a crucial role in providing innovative solutions to address the escalating prevalence of musculoskeletal disorders.

View More On The Joint Pain Injections Market Report 2024 – https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Development Of Farm Animal Vaccines

Innovations in Joint Pain Injections

Innovations in joint pain injections are pivotal in meeting the evolving needs of patients. Companies like Ono Pharmaceutical Co. Ltd. are introducing groundbreaking products, such as JOYCLU 30mg Intra-articular Injection, designed to improve joint function. This injection, launched in May 2021, focuses on treating knee and hip osteoarthritis, combining hyaluronic acid and the anti-inflammatory medication diclofenac.

Strategic Acquisitions for Market Expansion

Strategic acquisitions, such as Pacira BioSciences’ acquisition of Flexion Therapeutics for $630 million in October 2021, highlight significant industry moves. The acquisition aims to provide patients access to Zilretta, a non-opioid injection for pain treatment approved by the FDA for intra-articular therapy in osteoarthritis-related knee pain. This strategic move underscores the importance of acquisitions in strengthening market positions.

Market Segmentation and Major Trends

Comprehensive Market Segmentation

The joint pain injections market is segmented based on the type of injection, joint type, and distribution channel. Types of injections include steroid joint injection, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and others. Joint types range from hip joints to knee and ankle, shoulder and elbow, facet joints of the spine, and others. Distribution channels encompass hospital pharmacies, retail pharmacies, and online pharmacies.

Emerging Trends in the Forecast Period

Major trends expected in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, and AI-enhanced injections. These trends reflect the industry’s commitment to advancing treatment options, incorporating cutting-edge technologies, and enhancing patient outcomes.

Conclusion

In conclusion, the joint pain injections market is at the forefront of healthcare advancements, addressing the growing challenges posed by arthritis and musculoskeletal disorders. As the industry continues to evolve, stakeholders must remain vigilant to emerging trends and innovations that redefine pain management and improve the quality of life for patients. The joint pain injections market is not just a segment within healthcare; it represents a commitment to alleviating pain, restoring mobility, and empowering individuals to lead healthier lives.

Request A Sample Of The Global Joint Pain Injections Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6482&type=smp